A new methodology for polyvalent intravenous immunoglobulin solution production with a two-stage process of viral inactivation

Antônio Edson de Souza Lucena, Divaldo de Almeida Sampaio, Ednaldo Rosas da Silva, Virgínia Florêncio de Paiva, Ana Cláudia Santiago, Ana Cristina Lima Leite
2010 Brazilian Journal of Pharmaceutical Sciences  
Highly purified intravenous immunoglobulin G concentrate (IV IgG) was produced with the use of polyethylene glycol associated to a single-stage precipitation by ethanol, instead of the classic Cohn-Oncley process, which employs cold alcohol as the precipitating agent, in a three-stage process. Precipitation of crude fraction containing more than 95% of immunoglobulin G was performed by liquid chromatography with a cation exchanger, CM-Sepharose, as a stationary phase. During the process, the
more » ... the process, the product was subjected to two-stage viral inactivation. The first stage was performed by the action of sodium caprylate, 30 mM at pH 5.1+/- 0.1, and the second stage was performed by the action of a solvent-detergent mixture. The finished product was formulated at 5% with 10% sucralose as the stabilizing agent. The process yields 3.3g of IgG/liter of plasma. The finished product analysis showed an anti-complementary activity lower than 1CH50. Polymer and aggregate percent levels were lower than 3% in the five batches studied. The analysis of neutralizing capacity showed the presence of antibacterial and antiviral antibodies in at least three times higher concentrations than the levels found in source plasma. The finished product fulfilled all purity requirements stated in the 4th edition of the European pharmacopeia.
doi:10.1590/s1984-82502010000400020 fatcat:kipzccunhje57gwzbpdsal4gjm